| Company Name | Handa Pharmaceuticals, Inc. |
| Ticker Symbol | Handa Pharma |
| Stock Code | 6620 |
| Market | Emerging Stocks for Trading on the Taipei Exchange |
| Industry | Biotechnology and Medical Care |
| Establishment Date | 2014-05-08 |
| Listing Date | 2016-12-28 |
| OTC Listing Date | 2025-12-23 |
| Paid-up Capital | NT$ 1,699,831,000 |
| Chairman of the Board | Bill Liu, Ph.D. |
| General Manager | Mr. Toshiyo Chen |
| Stock Transfer Agent | Department of Stock Affairs and Transfer, Horizon Securities Co., Ltd. |
| Accounting Firm | Deloitte & Touche |
| Address | 3F-1&3F-2, No.23, Nanke 3rd Rd., Tainan City 74147, Taiwan (R.O.C.) |
| Telephone | +886-6-5057508 |
| Website | https://handapharma.com.tw |